Related Experiment Video
Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Putting the brakes on p53-driven apoptosis.
Katja Höpker1, Henning Hagmann, Safiya Khurshid
1Department II of Internal Medicine and Center for Molecular Medicine Cologne, Cologne, Germany.
The p38/MK2/AATF pathway controls whether cells undergo apoptosis or senescence after DNA damage. Inhibiting this pathway enhances chemotherapy effectiveness in tumor cells.
Area of Science:
- Cellular signaling pathways
- DNA damage response
- Cancer biology
Background:
- Genotoxic stress triggers complex signaling networks for DNA repair or apoptosis.
- The tumor suppressor p53 is central to the DNA damage response, mediating target gene expression.
- The precise molecular mechanisms dictating p53-dependent apoptosis versus senescence remain unclear.
Purpose of the Study:
- To elucidate the role of the transcriptional regulator AATF in determining the cellular outcome of p53 signaling.
- To identify novel signaling molecules that regulate the choice between p53-driven apoptosis and senescence.
- To investigate the p38/MK2/AATF pathway as a potential therapeutic target in cancer.
Main Methods:
- Investigated the phosphorylation and localization of AATF upon genotoxic stress.
- Examined the interaction of AATF with MRLC3 and its effect on nuclear translocation.
- Analyzed the binding of AATF to promoters of pro-apoptotic genes (PUMA, BAX, BAK).
- Assessed the impact of AATF depletion on tumor cell response to chemotherapeutics in vitro and in vivo.
- Correlated AATF copy number gains with prognosis in neuroblastoma.
Main Results:
- Genotoxic stress induces p38MAPK/MK2-mediated phosphorylation of cytoplasmic AATF.
- Phosphorylation disrupts AATF:MRLC3 complexes, leading to AATF nuclear localization.
- Nuclear AATF represses the expression of pro-apoptotic genes PUMA, BAX, and BAK.
- AATF depletion enhances tumor cell sensitivity to DNA-damaging agents.
- AATF copy number gains in neuroblastoma correlate with poor prognosis.
Conclusions:
- The p38/MK2/AATF signaling pathway acts as a critical repressor of p53-driven apoptosis in tumor cells.
- AATF's nuclear localization, regulated by p38/MK2, inhibits apoptosis.
- This pathway represents a novel target for therapies aimed at sensitizing tumors to chemotherapy.
More Related Videos
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...